Morpho, Inc.
Notice regarding the recording of special losses (investment securities fair value decrease and impairment losses)
Recorded 97 million yen as fair value decrease on investment securities and 22 million yen as impairment on fixed assets as special losses. These have been included in the Q3 2026 consolidated quarterly earnings release, and there is no impact on the full-year consolidated earnings guidance.
Key Figures
- Investment securities fair value decrease: 97 百万円（special loss）
- Impairment of fixed assets: 22 百万円（special loss）
- Current full-year consolidated earnings forecast: unchanged
AI要約
Performance overview
In the consolidated results for the third quarter of the fiscal year ending October 2026, the company recorded special losses for fair value decreases on investment securities and impairment of fixed assets. The fair value decrease on investment securities amounted to 97 million yen due to a decline in stock prices, and impairment of fixed assets was 22 million yen considering recoverable amounts. These have been disclosed in the earnings release published today, and there is no impact on the full-year earnings outlook.
Outlook and impact
The impact amount from the recording of these special losses does not meet the criteria to revise earnings guidance under timely disclosure rules, so there is no change to the full-year consolidated earnings forecast disclosed on June 12, 2026. The company will maintain its stance to preserve financial soundness while pursuing structural reforms.
Morpho, Inc.
Company overview · Stock price · Financial data · All IR
